
Exelixis Inc (EXEL) shares have recently traded above the average analyst 12-month target price of $28.28, reaching $28.50. This development typically prompts analysts to re-evaluate their targets or ratings, while investors are now encouraged to reassess the company's valuation for potential further upside or overextension. The average target is derived from 18 analysts, with current ratings predominantly "Strong Buy" (13 Strong Buy, 1 Buy) and an average rating of 1.65.
Exelixis Inc. (EXEL) has reached a critical inflection point as its share price of $28.50 has surpassed the average 12-month analyst price target of $28.28. This event typically forces a re-evaluation of the stock's valuation. The consensus target is derived from 18 analysts, whose views show significant dispersion, with individual targets ranging from a low of $23.00 to a high of $33.00, and a standard deviation of $2.396. While the overall sentiment remains strongly positive with 13 'Strong Buy' and 1 'Buy' rating, there has been a subtle shift in sentiment over the last two months. During this period, 'Hold' ratings increased from 5 to 6 while 'Strong Buy' ratings decreased from 14 to 13, causing the average rating to weaken slightly from 1.55 to 1.65. This indicates that as the stock price appreciated towards the consensus target, at least one analyst has tempered their bullishness, likely on valuation grounds.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment